PeakData, a Swiss health technology business, raised $12 million in a Series A round sponsored by AlbionVC, with participation from Octopus Ventures and Heal Capital.
According to Tech Funding News, PeakData has created an artificial intelligence (AI) platform that helps pharmaceutical businesses engage with the most pertinent and influential healthcare professionals (HCP).
PeakData, a Swiss health technology business, raised $12 million in a Series A round sponsored by AlbionVC, with participation from Octopus Ventures and Heal Capital.
According to Tech Funding News, PeakData has created an artificial intelligence (AI) platform that helps pharmaceutical businesses engage with the most pertinent and influential healthcare professionals (HCP).
Pharmaceutical businesses may follow and learn more about the HCPs most important to their initiatives by using the platform. According to the paper, the platform uses AI to rate HCPs according to their digital influence, relevancy, and impact on their target market while also monitoring their status over time.
According to Patrick De Boer, co-founder of PeakData, “We view PeakData as filling a major gap in the way our clients get and evaluate this data in order to better the dialogues they are having with a much larger range of HCPs in their region.”
PeakData intends to use the additional funding to enhance the platform and expand every element of its operations. The business intends to have its platform in as many pharma markets as feasible within the next five years, according to the article.
Finding the appropriate therapeutic experts and healthcare professionals for their medicines is extremely important for pharmaceutical companies, according to Christoph Ruedig, a partner at AlbionVC. With PeakData, they can now connect with local, national, and international medical professionals who influence clinical decision-making.
Research published in the HIPAA Journal states that between July 2021 and June 2022, 692 significant healthcare data breaches were recorded, exposing or improperly disclosing the details of 42,431,699 people.
